Propess Versus Prostin for Induction of Labour in Women With Term PROM (PESTIBOR)
Primary Purpose
Premature Rupture of Membranes at Term, Induction of Labour
Status
Unknown status
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Prostaglandin E2 (Propess)
Prostaglandin E2 (Prostin)
Sponsored by
About this trial
This is an interventional treatment trial for Premature Rupture of Membranes at Term focused on measuring Induction, PROM, Propess, Prostin
Eligibility Criteria
Inclusion Criteria:
- Age 18 years or older
- Gestational age 37 weeks or more
- Singleton pregnancy
- Cephalic presentation
- Unfavorable cervix (BISHOP <6)
- No contraindications for vaginal delivery
- Without uterine surgery
- Without chorioamnionitis
Exclusion Criteria:
- Age less than 18 years
- Multiple gestation
- Previous cesarean section
- Suspected intraamniotic infection
- Any contraindication to vaginal delivery
- Bishop score >7
- Pathological ctg
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Propess Vaginal Delivery System
Prostin Tablet
Arm Description
Propess - Prostaglandin E2 Vaginal Delivery System. Slow intravaginal release of 10 mg dinoprostone at a rate of 0.3 mg/h.
Prostaglandin E2 Vaginal Tablet 3 mg dinoprostone
Outcomes
Primary Outcome Measures
Induction to Delivery Interval
Induction to Onset of labor Interval
Secondary Outcome Measures
Frequency of Cesarean Sections
Frequency of Failed Induction
Full Information
NCT ID
NCT04743297
First Posted
January 26, 2021
Last Updated
February 9, 2021
Sponsor
University Medical Centre Maribor
1. Study Identification
Unique Protocol Identification Number
NCT04743297
Brief Title
Propess Versus Prostin for Induction of Labour in Women With Term PROM
Acronym
PESTIBOR
Official Title
Labour Induction With the Propess Vaginal Delivery System vs. Labour Induction With the Prostin Vaginal Tablet in Case of a Prelabour Rupture of Membranes. PESTIBOR Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
February 2021
Overall Recruitment Status
Unknown status
Study Start Date
March 2021 (Anticipated)
Primary Completion Date
January 2023 (Anticipated)
Study Completion Date
January 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Medical Centre Maribor
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Premature rupture of membranes (PROM) at term is a rupture that occurs at term (> 37 weeks) before the start of labor.
The purpose of the study was to compare the safety and efficacy of two agents used in induction of labor in women with term PROM Propess (Controlled release dinoprostone, Vaginal Delivery System) and Prostin E2 (Dinoprostone vaginal Tablet).
Women will be randomised to two treatment groups.
Although some studies support efficacy of the Propess for cervical ripening at term in induction of labor with intact membranes, it has not been well studied in women with PROM at term.
Detailed Description
The study is going to include all pregnant women with in-term PROM (after week 37 of pregnancy) without contractions if they meet the inclusion criteria. If the cervix is still non-inducible after 4-6 hours and there are no contractions, the medication to be administered to them will be determined by means of computer randomization. The success rate of induction with Propess vs. Prostin tablets will be compared. Soon after PROM, there can be the onset of contractions and cervix dilation that lead to childbirth.
In case of some pregnant women, there are no contractions and cervix dilation even after the event despite PROM and water breaking. If the status remains unchanged, the risk of intrauterine infection, fetus infection, and later on an infection of the newborn increases. The expecting mother can also eventually lose hope for a successful vaginal birth and starts thinking about having a caesarean delivery. To avoid that, the investigators use medications that accelerate the onset of vaginal birth in clinical practice.
The investigators know several ways to induce labour after PROM. References give no clear and reliable data on the best approach. The investigators can use medications such as oxytocin, dinoprostone, or misoprostol.
Our ward has been using Prostin 3 mg (dinoprostone) vaginal tablets to induce labour in case of PROM for several years. They have proven to be an efficient and safe procedure in our clinical practice.
Propess is used for the induction of labor with intact membranes. Based on the information from references and according to our experience, the medication is highly effective and safe, as well as easy to use.
Our study aims at establishing whether it can also be used with pregnant women with PROM.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Premature Rupture of Membranes at Term, Induction of Labour
Keywords
Induction, PROM, Propess, Prostin
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Model Description
Randomized Controlled Trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
526 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Propess Vaginal Delivery System
Arm Type
Active Comparator
Arm Description
Propess - Prostaglandin E2 Vaginal Delivery System. Slow intravaginal release of 10 mg dinoprostone at a rate of 0.3 mg/h.
Arm Title
Prostin Tablet
Arm Type
Active Comparator
Arm Description
Prostaglandin E2 Vaginal Tablet 3 mg dinoprostone
Intervention Type
Drug
Intervention Name(s)
Prostaglandin E2 (Propess)
Other Intervention Name(s)
dinoprostone
Intervention Description
Propess - The vaginal insert is removed 24 h after the application. It is only to be removed earlier in case of the onset of active labour or at the occurrence of hyperstimulation.
Intervention Type
Drug
Intervention Name(s)
Prostaglandin E2 (Prostin)
Other Intervention Name(s)
dinoprostone
Intervention Description
Prostin - 3 mg vaginal tablet is placed in the posterior vaginal fornix. Dose can be repeated every 8 hours till onset of active labour or the occurrence of hyper-stimulation.
Primary Outcome Measure Information:
Title
Induction to Delivery Interval
Time Frame
24 hours
Title
Induction to Onset of labor Interval
Time Frame
24 hours
Secondary Outcome Measure Information:
Title
Frequency of Cesarean Sections
Time Frame
24 hours
Title
Frequency of Failed Induction
Time Frame
24 hours
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
Women
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Age 18 years or older
Gestational age 37 weeks or more
Singleton pregnancy
Cephalic presentation
Unfavorable cervix (BISHOP <6)
No contraindications for vaginal delivery
Without uterine surgery
Without chorioamnionitis
Exclusion Criteria:
Age less than 18 years
Multiple gestation
Previous cesarean section
Suspected intraamniotic infection
Any contraindication to vaginal delivery
Bishop score >7
Pathological ctg
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Veronika Anzeljc
Phone
+ 386 2 321 21 73
Email
veronika.anzeljc@ukc-mb.si
First Name & Middle Initial & Last Name or Official Title & Degree
Faris Mujezinović
Phone
+ 386 2 321 24 08
Email
faris.mujezinovic@ukc-mb.si
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Veronika Anzeljc
Organizational Affiliation
Maribor University Medical Centre
Official's Role
Study Chair
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
32005186
Citation
Mynarek M, Bjellmo S, Lydersen S, Strand KM, Afset JE, Andersen GL, Vik T. Prelabor rupture of membranes and the association with cerebral palsy in term born children: a national registry-based cohort study. BMC Pregnancy Childbirth. 2020 Jan 31;20(1):67. doi: 10.1186/s12884-020-2751-3.
Results Reference
background
Citation
National Collaborating Centre for Women's and Children's Health. National Institute for Health and Care Excellence: Clinical Guidelines. Intrapartum Care: Care of Healthy Women and Their Babies During Childbirth. London: National Institute for Health and Care Excellence (UK) Copyright (c) 2014 National Collaborating Centre for Women's and Children's Health.; 2014
Results Reference
background
PubMed Identifier
8598837
Citation
Hannah ME, Ohlsson A, Farine D, Hewson SA, Hodnett ED, Myhr TL, Wang EE, Weston JA, Willan AR. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. TERMPROM Study Group. N Engl J Med. 1996 Apr 18;334(16):1005-10. doi: 10.1056/NEJM199604183341601.
Results Reference
background
PubMed Identifier
1630743
Citation
Zlatnik FJ. Management of premature rupture of membranes at term. Obstet Gynecol Clin North Am. 1992 Jun;19(2):353-64.
Results Reference
background
PubMed Identifier
30917724
Citation
Geethanath RM, Ahmed I, Abu-Harb M, Onwuneme C, McGarry K, Hinshaw K. Intrapartum antibiotics for prolonged rupture of membranes at term to prevent Group B Streptococcal sepsis. J Obstet Gynaecol. 2019 Jul;39(5):619-622. doi: 10.1080/01443615.2018.1550474. Epub 2019 Mar 27.
Results Reference
background
PubMed Identifier
27423032
Citation
Ivars J, Garabedian C, Devos P, Therby D, Carlier S, Deruelle P, Subtil D. Simplified Bishop score including parity predicts successful induction of labor. Eur J Obstet Gynecol Reprod Biol. 2016 Aug;203:309-14. doi: 10.1016/j.ejogrb.2016.06.007. Epub 2016 Jul 5.
Results Reference
background
PubMed Identifier
32585393
Citation
Athiel Y, Crequit S, Bongiorno M, Sanyan S, Renevier B. Term prelabor rupture of membranes: Foley catheter versus dinoprostone as ripening agent. J Gynecol Obstet Hum Reprod. 2020 Oct;49(8):101834. doi: 10.1016/j.jogoh.2020.101834. Epub 2020 Jun 22.
Results Reference
background
PubMed Identifier
31491801
Citation
Freret TS, Chacon KM, Bryant AS, Kaimal AJ, Clapp MA. Oxytocin Compared to Buccal Misoprostol for Induction of Labor after Term Prelabor Rupture of Membranes. Am J Perinatol. 2021 Feb;38(3):224-230. doi: 10.1055/s-0039-1696642. Epub 2019 Sep 6.
Results Reference
background
PubMed Identifier
16929421
Citation
Cheung PC, Yeo EL, Wong KS, Tang LC. Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstet Gynecol Scand. 2006;85(9):1128-33. doi: 10.1080/00016340600589636.
Results Reference
background
PubMed Identifier
31456315
Citation
Hu YP, Zhou D, Li M, Wang Y, Wang L, Sun GQ, Xiao M. Use of labor induction with dinoprostone vaginal suppositories in pregnant women with gestational hypertension. J Obstet Gynaecol Res. 2019 Nov;45(11):2185-2192. doi: 10.1111/jog.14092. Epub 2019 Aug 27.
Results Reference
background
PubMed Identifier
30317521
Citation
Shirley M. Dinoprostone Vaginal Insert: A Review in Cervical Ripening. Drugs. 2018 Oct;78(15):1615-1624. doi: 10.1007/s40265-018-0995-2.
Results Reference
background
Citation
Pajntar M, Lučovnik M. Normalni porod in vodenje poroda. v knjigi Nosečnost in vodenje poroda. Ured. Pajntar M, Novak Antolič Ž, Lučovnik M. Medicinski razgledi 2015. Tretja dopolnjena izdaja. 231-50.
Results Reference
background
Learn more about this trial
Propess Versus Prostin for Induction of Labour in Women With Term PROM
We'll reach out to this number within 24 hrs